FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns chemical pharmaceutical industry, particularly a medicine for treatment of viral disease, including HIV infection (AIDS and HIV related diseases). The antiviral medicine is a solution containing fullerene-polyhydropolyaminocaproic acid and dimethyl sulfoxide in the following component content per ampoule: fullerene-polyhydropolyaminocaproic acid 50 mg, dimethyl sulfoxide up to 0.5 ml. The medicine is intended for intramuscular or intravenous (drip-feed) administration, and dissolved in 20 ml of water for intramuscular administration, while the variant for intravenous administration includes additionally 20 ml of 0.9% sodium chloride solution per 1 ampoule.
EFFECT: obtaining antiviral medicine for treatment of virus diseases including HIV infection.
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333752C1 |
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333751C1 |
| ANTI-VIRAL AGENT FOR SYSTEMIC APPLICATION | 2006 |
|
RU2316321C1 |
| ANTI-VIRAL AGENT | 2006 |
|
RU2316320C1 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| HOMO- AND HETERO-POLYAMINO ACID FULLERENE C DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458914C1 |
| AGENT FOR INHIBITION OF REPRODUCTION OF ENVELOPED VIRUSES, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF VIRAL INFECTIONS | 2003 |
|
RU2236852C1 |
| PHARMACEUTICAL INJECTION COMPOSITION ON BASIS OF TILORONE FOR TREATMENT OF PURULENT-DESTRUCTIVE PROCESSES WITH SIGNS OF IMMUNE INSUFFICIENCY | 2007 |
|
RU2359664C1 |
| PHARMACEUTICAL INJECTION TILORONE-BASED COMPOSITION FOR TREATMENT OF DISEASES WITH IMMUNODEFICIENCY SIGNS | 2007 |
|
RU2364390C1 |
| METHOD FOR COMPLEX- INDIVIDUALIZED IMPACT UPON BODY AT SLOW VIRAL INFECTION AND METHOD FOR PREPARING LABORATORY ANIMAL FOR TESTING THE METHOD OF SUCH IMPACT | 2001 |
|
RU2207876C1 |
